Where does Biomet UK Healthcare Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biomet UK Healthcare Limited ranks #15,150 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biomet UK Healthcare Limited hold?

Biomet UK Healthcare Limited holds 19 US utility patents granted between 2015 and 2022, spanning 3 technology areas.

What is Biomet UK Healthcare Limited's Innovation Score?

Biomet UK Healthcare Limited has an Innovation Score of 31.4 out of 100 (38th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Biomet UK Healthcare Limited's patent grant rate increasing or decreasing?

Biomet UK Healthcare Limited's recent grant velocity is -54% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Biomet UK Healthcare Limited's patents?

Biomet UK Healthcare Limited's patents average 19.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biomet UK Healthcare Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Biomet UK Healthcare Limited

Q: What technology areas does Biomet UK Healthcare Limited focus on?

Biomet UK Healthcare Limited's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 17 patents, ranking #378 of 3,082 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 19 granted patents across 3 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biomet ranks #15,150 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 3 technology areas.

#15,150
of 49,997 US assignees by volume: 38th percentile
by Innovation Score (31.4/100): 19.4
avg claims per patent: -54%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15150 · Foreign Corporation #15,150 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 19 grants
MID-PACK #15,150/49,997
PHOTO-FINISH Betta Pharmaceuticals
CPC-NARROW A61F · 3 areas
INNOV-THIN 31.4/100
CLAIMS-RICH 19.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -54% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Betta Pharmaceuticals Co., Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biomet’s 31.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.3 pts (33%) Velocity 3.3 pts (11%) Breadth 6.1 pts (19%) Claim depth 11.6 pts (37%)

Qualcomm Incorporated · highest

85
Biomet UK Healthcare · this assignee

31
3D Lighting… · lowest

7

What this shows Biomet's Innovation Score is 31.4/100 (38th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biomet?

Each dot is one of Biomet’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biomet’s own 19.4 claims/patent is ABOVE the 11.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biomet vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biomet's grants concentrate

Biomet UK Healthcare Limited is a focused PatentsView assignee: 3 CPC subclasses with 89.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (6 grants) versus a trough of 1 in 2015. By volume, Biomet sits between Betta Pharmaceuticals Co., Ltd and Blanking Systems, Inc..

Biomet's three-year grant acceleration

Biomet UK Healthcare Limited shows 4 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Betta Pharmaceuti…

19
Betterup

19
Biolamina AB

19
Biological Illumi…

19
Biomet UK

19
Black Sesame Inte…

19
Blackfire Research

19
Blanking Systems

19
Biomet UK Healthc… ◀

19

What this shows Biomet holds 19 patents at rank #15,156, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biomet

By rank, the assignees closest to #15,156 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Biomet's primary technology class.

Biomet's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 38th percentile higher than 38% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Biomet UK Healthcare Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.3%
2016	1	5.3%
2017	4	21.1%
2018	1	5.3%
2019	6	31.6%
2020	2	10.5%
2022	4	21.1%

Which technologies does Biomet UK Healthcare Limited patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 17

A61B - DIAGNOSIS; SURGERY; Identification 9

C25D - Processes FOR THE Electrolytic OR Electrophoretic Production OF COATINGS; ELECTROFORMING; Apparatus Therefor 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biomet UK Healthcare Limited's patent record in context - here's where to go next.

Biomet UK Healthcare Limited's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 89.5% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #15,150 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biomet UK Healthcare Limited against Betta Pharmaceuticals Co., Ltd, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.